Bluejay Diagnostics Inc BJDX Q4 2023 Earnings EPS Misses Estimates by a Wide Margin Amid Continued Operational Challenges Dogwood Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued Preclinical Development TATT Q1 2026 Earnings Strong EPS Beat Signals Momentum in Aerospace Defense UTZ Q1 2026 Earnings EPS Beats Estimates Stock Edges Lower on Mixed Sentiment FULTP Q1 2026 Earnings Preferred Stock Delivers EPS Beat Despite Market Headwinds BAC Q1 2026 Earnings Earnings Beat with 86 Surprise